{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:56:35Z","timestamp":1776603395495,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:00:00Z","timestamp":1728950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jtha.2024.09.023","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T10:12:49Z","timestamp":1728555169000},"page":"190-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2830-4968","authenticated-orcid":false,"given":"Mette","family":"S\u00f8gaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"\u00d8rskov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamilla","family":"Goedegebuur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva K.","family":"Kempers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric C.T.","family":"Geijteman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Abbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P.","family":"Mooijaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert-Jan","family":"Geersing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanneke","family":"Portielje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette A.","family":"H\u00f8jen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Noble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Gulbech","family":"Ording","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.09.023_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jtha.2024.09.023_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00520-008-0541-y","article-title":"Futile medication use in terminally ill cancer patients","volume":"17","author":"Riechelmann","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtha.2024.09.023_bib3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00520-010-0947-1","article-title":"Use of unnecessary medications by patients with advanced cancer: cross-sectional survey","volume":"19","author":"Fede","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtha.2024.09.023_bib4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/pds.5223","article-title":"Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases","volume":"30","author":"Bosetti","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jtha.2024.09.023_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2021.23695","article-title":"Shifting to serious illness communication","volume":"327","author":"Jacobsen","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.09.023_bib6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jamaoto.2014.1570","article-title":"Unintended consequences of expensive cancer therapeutics\u2014the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity","volume":"140","author":"Fojo","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jtha.2024.09.023_bib7","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S1470-2045(17)30582-X","article-title":"Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care","volume":"18","author":"Rietjens","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtha.2024.09.023_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12904-021-00786-3","article-title":"Use of antithrombotics at the end of life: an in-depth chart review study","volume":"20","author":"Huisman","year":"2021","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jtha.2024.09.023_bib9","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.09.023_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2024.09.023_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.09.023_bib12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0041-1726298","article-title":"Single, dual, and triple antithrombotic therapy in cancer patients with coronary artery disease: searching for evidence and personalized approaches","volume":"47","author":"Santoro","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.09.023_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006544","article-title":"Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis","volume":"4","author":"Anderson","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2024.09.023_bib14","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/aje\/kwab018","article-title":"Trends in frailty and its association with mortality: results from the longitudinal aging study Amsterdam, 1995-2016","volume":"190","author":"Hoogendijk","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jtha.2024.09.023_bib15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.amjmed.2017.02.028","article-title":"Choosing wisely? Measuring the burden of medications in older adults near the end of life: nationwide, longitudinal cohort study","volume":"130","author":"Morin","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2024.09.023_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1049909118794926","article-title":"Prevalence of preventive and symptomatic drug treatments in hospice care: an Italian observational study","volume":"36","author":"Pasina","year":"2019","journal-title":"Am J Hosp Palliat Med"},{"key":"10.1016\/j.jtha.2024.09.023_bib17","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/j.1538-7836.2006.02082.x","article-title":"Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry","volume":"4","author":"Monreal","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.09.023_bib18","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1136\/bmjspcare-2019-001804","article-title":"Management of venous thromboembolism in far-advanced cancer: current practice","volume":"12","author":"Noble","year":"2022","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jtha.2024.09.023_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2023.05.008","article-title":"Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool","volume":"228","author":"Goedegebuur","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.09.023_bib20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.jtha.2024.09.023_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2024.09.023_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.jtha.2024.09.023_bib23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jtha.2024.09.023_bib24","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jtha.2024.09.023_bib25","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1200\/JCO.2005.16.493","article-title":"Defining cancer patients as being in the terminal phase: who receives a formal diagnosis, and what are the effects?","volume":"23","author":"Aabom","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtha.2024.09.023_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jtha.2024.09.023_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bcpt.12664","article-title":"Treatment changes among users of non-vitamin K antagonist oral anticoagulants in atrial fibrillation","volume":"120","author":"Hellfritzsch","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jtha.2024.09.023_bib28","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.09.023_bib29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.jtha.2024.09.023_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"Schulman","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.09.023_bib31","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.09.023_bib32","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jamda.2016.01.015","article-title":"Changes in prescribed drugs between admission and the end of life in patients admitted to palliative care facilities","volume":"17","author":"van Nordennen","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jtha.2024.09.023_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s41999-020-00315-0","article-title":"Inappropriate medications among end-of-life patients living at home: an Italian observational study","volume":"11","author":"Pasina","year":"2020","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jtha.2024.09.023_bib34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamainternmed.2021.1819","article-title":"Anticoagulant use for atrial fibrillation among persons with advanced dementia at the end of life","volume":"181","author":"Ouellet","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2024.09.023_bib35","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1002\/cncr.25284","article-title":"Predictors of anticoagulation in hospice patients with lung cancer","volume":"116","author":"Holmes","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jtha.2024.09.023_bib36","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/jpm.2016.0487","article-title":"Prevalence and clinical intentions of antithrombotic therapy on discharge to hospice care","volume":"20","author":"Kowalewska","year":"2017","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jtha.2024.09.023_bib37","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2147\/CIA.S174896","article-title":"Antithrombotic therapies for elderly patients: handling problems originating from their comorbidities","volume":"13","author":"Arahata","year":"2018","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jtha.2024.09.023_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/ecc.13210","article-title":"Chemotherapy and tyrosine kinase inhibitors in the last month of life in patients with metastatic lung cancer: a patient file study in the Netherlands","volume":"29","author":"Mieras","year":"2020","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.jtha.2024.09.023_bib39","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/annonc\/mdw654","article-title":"Use of chemotherapy near the end of life: what factors matter?","volume":"28","author":"Rochigneux","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtha.2024.09.023_bib40","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1200\/JOP.2016.013995","article-title":"Paradox of prescribing late chemotherapy: oncologists explain","volume":"12","author":"Bluhm","year":"2016","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.jtha.2024.09.023_bib41","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jamaoncol.2015.2378","article-title":"Chemotherapy use, performance status, and quality of life at the end of life","volume":"1","author":"Prigerson","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtha.2024.09.023_bib42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/0284186X.2021.1890332","article-title":"End-of-life anticancer treatment \u2013 a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies","volume":"60","author":"Mattsson","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jtha.2024.09.023_bib43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1055\/s-0041-1725115","article-title":"Physicians\u2019 opinions on anticoagulant therapy in patients with a limited life expectancy","volume":"47","author":"Huisman","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.09.023_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/bmjspcare-2012-000220","article-title":"Defining the palliative care patient: its challenges and implications for service delivery","volume":"3","author":"Mitchell","year":"2013","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jtha.2024.09.023_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jech-2018-211580","article-title":"Socioeconomic inequality in drug reimbursement during end-of-life care: a nationwide study","volume":"73","author":"Daugaard","year":"2019","journal-title":"J\u00a0Epidemiol Community Health"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624005713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624005713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:44:58Z","timestamp":1738208698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624005713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1538783624005713"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.09.023","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}